Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 USD | +5.88% | +14.72% | +18.89% |
04-19 | Venture Life renews revolving credit facility with Santander and HSBC | AN |
04-18 | Jaguar Health, Inc. Appoints Catherine Miller Collis to the Role of Senior Vice President of Growth Strategy | CI |
Sales 2022 | 11.96M 957M | Sales 2023 | 9.76M 781M | Capitalization | 7.68M 615M |
---|---|---|---|---|---|
Net income 2022 | -47M -3.76B | Net income 2023 | -41M -3.28B | EV / Sales 2022 | 4.65 x |
Net Debt 2022 | 29.37M 2.35B | Net Debt 2023 | 30.62M 2.45B | EV / Sales 2023 | 3.92 x |
P/E ratio 2022 |
-0.18
x | P/E ratio 2023 |
-0.08
x | Employees | 49 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.22% |
Latest transcript on Jaguar Health, Inc.
1 day | +5.88% | ||
1 week | +14.72% | ||
Current month | +100.22% | ||
1 month | +146.91% | ||
3 months | +59.86% | ||
6 months | -44.62% | ||
Current year | +18.89% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 30/04/19 |
Chief Tech/Sci/R&D Officer | 60 | 30/04/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
James Bochnowski
CHM | Chairman | 80 | 31/01/14 |
John Micek
BRD | Director/Board Member | 71 | 31/03/16 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.18 | +5.88% | 43,999,118 |
25/04/24 | 0.17 | +0.06% | 20,038,575 |
24/04/24 | 0.1699 | +1.13% | 34,588,990 |
23/04/24 | 0.168 | -6.61% | 40,003,810 |
22/04/24 | 0.1799 | +14.66% | 106,875,256 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+18.89% | 49.72M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- JAGX Stock